Josephine van Dongen

Chapter 8 200 References 1. Kotloff KL. The Burden and Etiology of Diarrheal Illness in Developing Countries. Pediatr Clin North Am . 2017;64(4):799-814. doi:10.1016/j.pcl.2017.03.006 2. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis . Published online 2003. doi:10.3201/ eid0905.020562 3. Verhagen P, Moore D, Manges A, Quach C. Nosocomial rotavirus gastroenteritis in a Canadian paediatric hospital: Incidence, disease burden and patients affected. J Hosp Infect. Published online 2011. doi:10.1016/j.jhin.2011.04.020 4. Bruijning-Verhagen P, Mangen M-JJ, Felderhof M, et al.Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination. BMC Med . 2013;11(112). doi:10.1186/1741-7015-11-112 5. Hungerford D, Smith K,Tucker A, et al. Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2017;17. doi:10.1186/s12879-017-2613-4 6. Burnett E, Parashar UD,Tate JE. Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis. Lancet Glob Heal. 2020;8(9):e1195-e1202. doi:10.1016/ S2214-109X(20)30262-X 7. OrganizationWH. Causality Assessment of an Adverse Event Following Immunization (AEFI): User Manual for the Revised WHO Classification (Second Edition).; 2018. http://www. who.int/vaccine_safety/publications/aefi_manual.pdf?ua=1 8. Blokhuis P. Changes in Neonatal Screening and Vaccination.; 2020. https://www. tweedekamer.nl/kamerstukken/brieven_regering/detail?id=2020Z07778&did=2020D16656 9. ToendersWGM. CFH-Rappor t Beoordeling Rotavirus RIX4414 (Rotarix).Vol 3.; 2007. 10. Gezondheidsraad (Health Council of the Netherlands). Het individuele, collectieve en publieke belang van vaccinatie. Published online 2013:1-86. 11. de Vrieze J. Het vaccinatieprogramma van de overheid is te behoudend. de Groene Amsterdammer. Published online 2019. 12. Moerkamp AH., van Gool WA, Dutch Health Institute. Note of Dutch Health Council and Institute of Health by advices on vaccination against rotavirus. Published online 2017. 13. Blokhuis P. Offering rotavirus vaccine to risk group infants. Lett to Parliam. Published online 2018:1-2. 14. Blokhuis P. Postponement of rotavirus vaccination for risk groups. Letter to Parliament. Published 2019. Accessed February 26, 2021. https://www.tweedekamer.nl/kamerstukken/ brieven_regering/detail?id=2019D20882 15. Blokhuis P. Aanvraag Gezondheidsraad Update Rotavirus-Advies.; 2020. 16. World Health Organization. Vaccine Introduction Status. Published 2020. Accessed February 8, 2021. www. who.int/immunization/monitoring_surveil lance/ VaccineIntroStatus. pptx?ua=1 17. Roué JM, Nowak E, Le Gal G, et al. Impact of rotavirus vaccine on premature infants. Clin Vaccine Immunol. 2014;21(10):1404-1409. doi:10.1128/CVI.00265-14 18. Dahl RM, Curns AT, Tate JE, Parashar UD. Effect of rotavirus vaccination on acute diarrheal hospitalizations among low and very low bir th weight US infants, 2001-2015. Pediatr Infect Dis J . 2018;37(8):817-822. doi:10.1097/INF.0000000000001930 19. Schurink-van t Klooster TM, de Melker HE.The National Immmunisation Programme in the Netherlands: Surveillance and developments. Natl Inst Public Heal Environ . Published online 2019:102-125. doi:10.1007/978-94-6265-282-8_2